Ortoma AB (publ) (STO:ORT.B)

Market Cap	465.40M
Revenue (ttm)	92.57M
Net Income (ttm)	10.27M
Shares Out	37.08M
EPS (ttm)	0.28
PE Ratio	45.30
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	33,315
Average Volume	24,687
Open	13.15
Previous Close	13.00
Day's Range	12.55 - 13.70
52-Week Range	6.90 - 15.20
Beta	0.67
RSI	57.53
Earnings Date	Aug 20, 2025

About Ortoma AB

Ortoma AB (publ) provides orthopedic surgical products for use in joint implant surgery in Sweden. It offers Ortoma Treatment Solution (OTS) that is designed to support various orthopedic joint or spine surgeries in the areas of hip, spine, knee, and shoulders and extremities surgeries; OTS Plan, a software that processes and assists surgeons during pre-operative planning and post-operative follow-up; OTS Guide, an intra-operative navigation tool guiding surgeons to place the implant in the pre-operatively planned position; and OTS Follow up th...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2001
• Employees: 10
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ORT.B

Financial Performance

In 2024, Ortoma AB's revenue was 60.59 million, a decrease of -2.29% compared to the previous year's 62.01 million. Losses were -11.63 million, -46.83% less than in 2023.